<VariationArchive VariationID="4506" VariationName="NM_016180.5(SLC45A2):c.1121del (p.Leu374fs)" VariationType="Deletion" Accession="VCV000004506" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2015-02-13" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19545" VariationID="4506">
      <GeneList>
        <Gene Symbol="SLC45A2" FullName="solute carrier family 45 member 2" GeneID="51151" HGNC_ID="HGNC:16472" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="33944623" stop="33984693" display_start="33944623" display_stop="33984693" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NT_187551.1" start="145945" stop="155829" display_start="145945" display_stop="155829" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="33944720" stop="33984779" display_start="33944720" display_stop="33984779" Strand="-" />
          </Location>
          <OMIM>606202</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_016180.5(SLC45A2):c.1121del (p.Leu374fs)</Name>
      <CanonicalSPDI>NC_000005.10:33951588:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="33951589" stop="33951589" display_start="33951589" display_stop="33951589" variantLength="1" positionVCF="33951588" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="33951694" stop="33951694" display_start="33951694" display_stop="33951694" variantLength="1" positionVCF="33951693" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>L374fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001012509.4" sequenceAccession="NM_001012509" sequenceVersion="4" change="c.1121del">
            <Expression>NM_001012509.4:c.1121del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001012527.2" sequenceAccession="NP_001012527" sequenceVersion="2" change="p.Leu374fs">
            <Expression>NP_001012527.2:p.Leu374fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001297417.4" sequenceAccession="NM_001297417" sequenceVersion="4" change="c.*63del">
            <Expression>NM_001297417.4:c.*63del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016180.5" sequenceAccession="NM_016180" sequenceVersion="5" change="c.1121del" MANESelect="true">
            <Expression>NM_016180.5:c.1121del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057264.4" sequenceAccession="NP_057264" sequenceVersion="4" change="p.Leu374fs">
            <Expression>NP_057264.4:p.Leu374fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.33951590del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.33951590del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.33951695del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.33951695del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011691.2" sequenceAccession="NG_011691" sequenceVersion="2" change="g.38087del">
            <Expression>NG_011691.2:g.38087del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA253183" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606202.0009" DB="OMIM" />
        <XRef Type="rs" ID="730880271" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 16868655 Fig. 3 to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_016180.5(SLC45A2):c.1121del (p.Leu374fs) AND Oculocutaneous albinism type 4" Accession="RCV000004764" Version="5">
        <ClassifiedConditionList TraitSetID="1241">
          <ClassifiedCondition DB="MedGen" ID="C1847836">Oculocutaneous albinism type 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_016180.5(SLC45A2):c.1121del (p.Leu374fs) AND not provided" Accession="RCV002512771" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-02-13" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14070830</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16868655</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21458243</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26573111</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1241" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5663" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Albinism, oculocutaneous, type IV</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Oculocutaneous albinism type 4</ElementValue>
                <XRef ID="Oculocutaneous+albinism%2C+type+4/9033" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011683" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OCA4</ElementValue>
                <XRef Type="MIM" ID="606574" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Oculocutaneous albinism type 4 (OCA4) is characterized by hypopigmentation of the hair and skin plus the characteristic ocular changes found in all other types of albinism, including: nystagmus; reduced iris pigment with iris translucency; reduced retinal pigment with visualization of the choroidal blood vessels on ophthalmoscopic examination; foveal hypoplasia associated with reduction in visual acuity; and misrouting of the optic nerves at the chiasm associated with alternating strabismus, reduced stereoscopic vision, and an altered visual evoked potential (VEP). Individuals with OCA4 are usually recognized within the first year of life because of hypopigmentation of the hair and skin and the ocular features of nystagmus and strabismus. Vision is likely to be stable after early childhood. The amount of cutaneous pigmentation in OCA4 ranges from minimal to near normal. Newborns with OCA4 usually have some pigment in their hair, with color ranging from silvery white to light yellow. Hair color may darken with time, but does not vary significantly from childhood to adulthood.</Attribute>
                <XRef ID="NBK1510" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16722" />
                <XRef ID="16722" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301683</ID>
                <ID Source="BookShelf">NBK1510</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">37053367</ID>
                <ID Source="BookShelf">NBK590568</ID>
              </Citation>
              <XRef ID="79435" DB="Orphanet" />
              <XRef ID="C1847836" DB="MedGen" />
              <XRef ID="MONDO:0011683" DB="MONDO" />
              <XRef Type="MIM" ID="606574" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24940" SubmissionDate="2018-02-13" DateLastUpdated="2015-02-13" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606202.0009_OCULOCUTANEOUS ALBINISM, TYPE IV" title="SLC45A2, 1-BP DEL, 1121T_OCULOCUTANEOUS ALBINISM, TYPE IV" />
        <ClinVarAccession Accession="SCV000024940" DateUpdated="2015-02-13" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 Brazilian sibs with oculocutaneous albinism type IV (OCA4; 606574), Lezirovitz et al. (2006) identified a homozygous 1-bp deletion (1121delT) in exon 5 of the MATP gene, resulting in a frameshift and premature termination of the protein at codon 397. One of the affected sibs also had sensorineural deafness (DFNB1; 220290) associated with a homozygous mutation in the GJB2 gene (121011.0005). Lezirovitz et al. (2006) concluded that congenital deafness and oculocutaneous albinism due to mutations in 2 different genes as seen in their Brazilian family suggested a similar coincident inheritance of 2 separate recessive disorders in the Sephardic family reported by Ziprkowski and Adam (1964) (see 220900).</Attribute>
              <Citation>
                <ID Source="PubMed">16868655</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">14070830</ID>
              </Citation>
              <XRef DB="OMIM" ID="606574" Type="MIM" />
              <XRef DB="OMIM" ID="220290" Type="MIM" />
              <XRef DB="OMIM" ID="220900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC45A2" />
          </GeneList>
          <Name>SLC45A2, 1-BP DEL, 1121T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1121T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606202.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OCULOCUTANEOUS ALBINISM, TYPE IV</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6214943" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4853718|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003525904" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16868655</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21458243</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26573111</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 4506). This premature translational stop signal has been observed in individual(s) with oculocutaneous albinism (PMID: 16868655). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe374Serfs*24) in the SLC45A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC45A2 are known to be pathogenic (PMID: 21458243, 26573111).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC45A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.33951694del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="24940" TraitType="Disease" MappingType="Name" MappingValue="OCULOCUTANEOUS ALBINISM, TYPE IV" MappingRef="Preferred">
        <MedGen CUI="C1847836" Name="Oculocutaneous albinism type 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6214943" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

